id stringlengths 40 40 | source stringclasses 9
values | title stringlengths 2 345 | clean_text stringlengths 35 1.63M | raw_text stringlengths 4 1.63M | url stringlengths 4 498 | overview stringlengths 0 10k |
|---|---|---|---|---|---|---|
1da4bb3360fa61438d755c1343d868fb4a8606b6 | wikidoc | List of ICD-9 codes 240-279: Endocrine, nutritional and metabolic diseases, and immunity disorders | List of ICD-9 codes 240-279: Endocrine, nutritional and metabolic diseases, and immunity disorders
# 3. Endocrine, nutritional and metabolic diseases, and immunity disorders (240-279)
## disorders of thyroid gland (240-246)
- (240) Simple and unspecified goiter
(240.9) Goiter, unspec.
- (240.9) Goiter, unspec.
- (241... | List of ICD-9 codes 240-279: Endocrine, nutritional and metabolic diseases, and immunity disorders
# 3. Endocrine, nutritional and metabolic diseases, and immunity disorders (240-279)
## disorders of thyroid gland (240-246)
- (240) Simple and unspecified goiter
(240.9) Goiter, unspec.
- (240.9) Goiter, unspec.
- (241... | https://www.wikidoc.org/index.php/List_of_ICD-9_codes_240-279:_Endocrine,_nutritional_and_metabolic_diseases,_and_immunity_disorders | |
df210bd4ec19579f4f86416a966252de90182be8 | wikidoc | ACC/AHA guidelines-recommendations for permanent pacing in patients with congenital heart disease | ACC/AHA guidelines-recommendations for permanent pacing in patients with congenital heart disease
ACC / AHA Guidelines-Recommendations for Permanent Pacing in Children, Adolescents, and Patients With Congenital(DO NOT EDIT) ==
- ↑ Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM III, Freedman RA, Gettes LS, Gillinov A... | ACC/AHA guidelines-recommendations for permanent pacing in patients with congenital heart disease
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Associate Editor-In-Chief: Keri Shafer, M.D. [2]
Associate Editor-In-Chief::Atif Mohammad, M.D.
ACC / AHA Guidelines-Recommendations for Permanent Pacing in Children, Ado... | https://www.wikidoc.org/index.php/ACC/AHA_guidelines-recommendations_for_permanent_pacing_in_patients_with_congenital_heart_disease | |
5e6baa98eca6075d52bed81198072c345f165bfa | wikidoc | Duplex Ultrasonography to Evaluate Asymptomatic Patients With Known or Suspected Carotid Stenosis | Duplex Ultrasonography to Evaluate Asymptomatic Patients With Known or Suspected Carotid Stenosis
# Diagnostic Testing Guidelines
## 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease (DO NOT EDIT)
### Dia... | Duplex Ultrasonography to Evaluate Asymptomatic Patients With Known or Suspected Carotid Stenosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
# Diagnostic Testing Guidelines
## 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid... | https://www.wikidoc.org/index.php/Duplex_Ultrasonography_to_Evaluate_Asymptomatic_Patients_With_Known_or_Suspected_Carotid_Stenosis | |
9cb90fdea1c334123786c6656213d2286e89e1b6 | wikidoc | The Living Guidelines: Maintenance of sinus rhythm: Suggest Revisions to the CLASS IIa Guidelines | The Living Guidelines: Maintenance of sinus rhythm: Suggest Revisions to the CLASS IIa Guidelines
# Class IIa Guidelines
- Pharmacological therapy can be useful in patients with AF to maintain sinus rhythm and prevent tachycardia induced cardiomyopathy. (Level of Evidence: C)
- Infrequent, well-tolerated recurrence o... | The Living Guidelines: Maintenance of sinus rhythm: Suggest Revisions to the CLASS IIa Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for i... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Maintenance_of_sinus_rhythm:_Suggest_Revisions_to_the_CLASS_IIa_Guidelines | |
864c1b6916c581e47e27b13526976570e73e45ff | wikidoc | The Living Guidelines: Patients with hyperthyroidism: Suggest Revisions to the CLASS I Guidelines | The Living Guidelines: Patients with hyperthyroidism: Suggest Revisions to the CLASS I Guidelines
# Class I Guidelines
- Administration of a beta blocker is recommended to control the rate of ventricular response in patients with AF complicating thyrotoxicosis, unless contraindicated. (Level of Evidence: B)
- In circ... | The Living Guidelines: Patients with hyperthyroidism: Suggest Revisions to the CLASS I Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for i... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Patients_with_hyperthyroidism:_Suggest_Revisions_to_the_CLASS_I_Guidelines | |
2161a723f6d62e36f3a1be7d735775c5263350bc | wikidoc | Elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate (patient information) | Elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate (patient information)
Important: Ask your healthcare provider or pharmacist about medicines that should not be taken with STRIBILD. For more information, see the section "What should I tell my healthcare provider before taking STRIBILD?"
Read th... | Elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate (patient information)
Template:Drug header
Important: Ask your healthcare provider or pharmacist about medicines that should not be taken with STRIBILD. For more information, see the section "What should I tell my healthcare provider before tak... | https://www.wikidoc.org/index.php/Elvitegravir,_cobicistat,_emtricitabine,_and_tenofovir_disoproxil_fumarate_(patient_information) | |
73bf81c7afa067d28e8545e33347840f28ee0944 | wikidoc | HIV opportunistic infection toxoplasma gondii encephalitis: prevention and treatment guidelines | HIV opportunistic infection toxoplasma gondii encephalitis: prevention and treatment guidelines
# Overview
Toxoplasmic encephalitis (TE) is caused by the protozoan Toxoplasma gondii. Disease appears to occur almost exclusively because of reactivation of latent tissue cysts.
# Guidelines for Prevention and Treatment o... | HIV opportunistic infection toxoplasma gondii encephalitis: prevention and treatment guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief:, Ujjwal Rastogi, MBBS [2]
# Overview
Toxoplasmic encephalitis (TE) is caused by the protozoan Toxoplasma gondii. Disease appears to occur al... | https://www.wikidoc.org/index.php/HIV_opportunistic_infection_toxoplasma_gondii_encephalitis:_prevention_and_treatment | |
e7c5d65fa683c9c5e444176ca2882265eaf4b374 | wikidoc | The Living Guidelines: Preventing Thromboembolism Suggest Revisions to the CLASS IIa Guidelines | The Living Guidelines: Preventing Thromboembolism Suggest Revisions to the CLASS IIa Guidelines
# Class IIa Guidelines
- For primary prevention of thromboembolism in patients with non valvular AF who have just 1 of the following validated risk factors, antithrombotic therapy with either aspirin or a vitamin K antagoni... | The Living Guidelines: Preventing Thromboembolism Suggest Revisions to the CLASS IIa Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for imp... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Preventing_Thromboembolism_Suggest_Revisions_to_the_CLASS_IIa_Guidelines | |
f7bb9870b126a230ee11d4d99612bcb2207f40db | wikidoc | The Living Guidelines: Preventing Thromboembolism Suggest Revisions to the CLASS IIb Guidelines | The Living Guidelines: Preventing Thromboembolism Suggest Revisions to the CLASS IIb Guidelines
# Class IIb Guidelines
- In patients 75 y of age and older at increased risk of bleeding but without frank contraindications to oral anticoagulant therapy, and in other patients with moderate risk factors for thromboembolis... | The Living Guidelines: Preventing Thromboembolism Suggest Revisions to the CLASS IIb Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for imp... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Preventing_Thromboembolism_Suggest_Revisions_to_the_CLASS_IIb_Guidelines | |
6e543cea1a57f452a3f38b5711249e659bf8aadc | wikidoc | United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances | United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances
The 1988 United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances is one of three major drug control treaties currently in force. It provides additional legal mechanisms for enforcing t... | United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances
Template:Treatybox
The 1988 United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances is one of three major drug control treaties currently in force. It provides additional legal mechan... | https://www.wikidoc.org/index.php/United_Nations_Convention_Against_Illicit_Traffic_in_Narcotic_Drugs_and_Psychotropic_Substances | |
f3b92baf772386e380f5a151c21aa88b64691ee2 | wikidoc | Clopidogrel For High Atherothrombotic Risk, Ischemic Stabilization, Management, And Avoidance | Clopidogrel For High Atherothrombotic Risk, Ischemic Stabilization, Management, And Avoidance
# Complete Title of Study
A Phase III, Multicenter, Multinational, Randomized, Parallel Group, Double-Blind Trial of Clopidogrel Versus Placebo in High-Risk Patients Aged 45 Years and Older, at Risk of Atherothrombotic Events... | Clopidogrel For High Atherothrombotic Risk, Ischemic Stabilization, Management, And Avoidance
# Complete Title of Study
A Phase III, Multicenter, Multinational, Randomized, Parallel Group, Double-Blind Trial of Clopidogrel Versus Placebo in High-Risk Patients Aged 45 Years and Older, at Risk of Atherothrombotic Events... | https://www.wikidoc.org/index.php/CHARISMA | |
c412a542950b3f10f3c042c34616241236106bb2 | wikidoc | The Living Guidelines: Preventing Thromboembolism Suggest Revisions to the CLASS I Guidelines | The Living Guidelines: Preventing Thromboembolism Suggest Revisions to the CLASS I Guidelines
# Class I Guidelines
- Antithrombotic therapy to prevent thromboembolism is recommended for all patients with AF, except those with lone AF or contraindications. (Level of Evidence: A)
- The selection of the antithrombotic a... | The Living Guidelines: Preventing Thromboembolism Suggest Revisions to the CLASS I Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for impor... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Preventing_Thromboembolism_Suggest_Revisions_to_the_CLASS_I_Guidelines | |
76695ef88c5177ee652cdf6b32fe6a0cad2bf570 | wikidoc | Management of Patients With Occlusive Disease of the Subclavian and Brachiocephalic Arteries | Management of Patients With Occlusive Disease of the Subclavian and Brachiocephalic Arteries
# Management of Patients With Occlusive Disease of the Subclavian and Brachiocephalic Arteries
## 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS: Guideline on the Management of Patients With Extracranial ... | Management of Patients With Occlusive Disease of the Subclavian and Brachiocephalic Arteries
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
# Management of Patients With Occlusive Disease of the Subclavian and Brachiocephalic Arteries
## 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS: Guidel... | https://www.wikidoc.org/index.php/Management_of_Patients_With_Occlusive_Disease_of_the_Subclavian_and_Brachiocephalic_Arteries | |
81b49ca3615e87aee8c35b25b63e44b7bf6c49d5 | wikidoc | Statins found to be protective against recurrence of atrial fibrillation after cardioversion | Statins found to be protective against recurrence of atrial fibrillation after cardioversion
November 17, 2007 By Benjamin A. Olenchock, M.D. Ph.D.
Vancouver, Canada
A new retrospective study has found that patients with atrial fibrillation who have sinus rhythm successfully restored were less likely to return to atri... | Statins found to be protective against recurrence of atrial fibrillation after cardioversion
November 17, 2007 By Benjamin A. Olenchock, M.D. Ph.D. [1]
Vancouver, Canada
A new retrospective study has found that patients with atrial fibrillation who have sinus rhythm successfully restored were less likely to return to ... | https://www.wikidoc.org/index.php/Statins_found_to_be_protective_against_recurrence_of_atrial_fibrillation_after_cardioversion | |
dafbde3d56cf347add28018f82804a99077f943c | wikidoc | The Living Guidelines: Maintenance of sinus rhythm: Polling Results for CLASS IIa Guidelines | The Living Guidelines: Maintenance of sinus rhythm: Polling Results for CLASS IIa Guidelines
# Class IIa Guidelines
1. Pharmacological therapy can be useful in patients with AF to maintain sinus rhythm and prevent tachycardia induced cardiomyopathy. (Level of Evidence: C)
ACC / AHA 2008 guidelines for diagnosis and m... | The Living Guidelines: Maintenance of sinus rhythm: Polling Results for CLASS IIa Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for import... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Maintenance_of_sinus_rhythm:_Polling_Results_for_CLASS_IIa_Guidelines | |
4dba48befbee3eaebcb2ba524e80bf62079b9e53 | wikidoc | The Living Guidelines: Patients with hyperthyroidism: Polling Results for CLASS I Guidelines | The Living Guidelines: Patients with hyperthyroidism: Polling Results for CLASS I Guidelines
# Class I Guidelines
1. Administration of a beta blocker is recommended to control the rate of ventricular response in patients with AF complicating thyrotoxicosis, unless contraindicated. (Level of Evidence: B)
ACC / AHA 200... | The Living Guidelines: Patients with hyperthyroidism: Polling Results for CLASS I Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for import... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Patients_with_hyperthyroidism:_Polling_Results_for_CLASS_I_Guidelines | |
5f04e319f8170170e3806170a7ecdccb40daeda2 | wikidoc | ACC/AHA recommendations for evaluation of patients with unoperated patent ductus arteriosus | ACC/AHA recommendations for evaluation of patients with unoperated patent ductus arteriosus
# Overview
The ACC/AHA has given recommendations for evaluation of unoperated patient with patent ductus arteriosus
# 2008 ACC/AHA Guidelines for the Management of Adults With Congenital Heart Disease (DO NOT EDIT)
## Recomme... | ACC/AHA recommendations for evaluation of patients with unoperated patent ductus arteriosus
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Priyamvada Singh, M.B.B.S. [2], Cafer Zorkun, M.D., Ph.D. [3]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [4]
# Overview
The ACC/AHA has given... | https://www.wikidoc.org/index.php/ACC/AHA_recommendations_for_evaluation_of_patients_with_unoperated_patent_ductus_arteriosus | |
1cbaf89808a372953de1c7fe3a104c07a020a935 | wikidoc | Platelet monitoring can improve outcomes following PCI among clopidogrel resistant patients | Platelet monitoring can improve outcomes following PCI among clopidogrel resistant patients
March 29, 2008 By Lauren Ciaglo
SCAI-ACCi2 08-Chicago, IL: Investigators from France demonstrate that platelet monitoring of clopidogrel response using VASP phosphorylation index decreases the rate of major adverse cardiovascula... | Platelet monitoring can improve outcomes following PCI among clopidogrel resistant patients
March 29, 2008 By Lauren Ciaglo
SCAI-ACCi2 08-Chicago, IL: Investigators from France demonstrate that platelet monitoring of clopidogrel response using VASP phosphorylation index decreases the rate of major adverse cardiovascul... | https://www.wikidoc.org/index.php/Platelet_monitoring_can_improve_outcomes_following_PCI_among_clopidogrel_resistant_patients | |
511fdcb488d2f97a447695327a3f4e1d2d1d724f | wikidoc | Rhythm Control Demonstrated as Equally Effective as Rate Control in Preventing CV Mortality | Rhythm Control Demonstrated as Equally Effective as Rate Control in Preventing CV Mortality
November 6, 2007 By Scott Williams
Orlando, FL: The AF-CHF trial demonstrated no differences in cardiovascular mortality among patients with atrial fibrillation (AF) and heart failure (HF) in either the rhythm control or rate ... | Rhythm Control Demonstrated as Equally Effective as Rate Control in Preventing CV Mortality
November 6, 2007 By Scott Williams [1]
Orlando, FL: The AF-CHF trial demonstrated no differences in cardiovascular mortality among patients with atrial fibrillation (AF) and heart failure (HF) in either the rhythm control or r... | https://www.wikidoc.org/index.php/Rhythm_Control_Demonstrated_as_Equally_Effective_as_Rate_Control_in_Preventing_CV_Mortality | |
8502631b403b91dac92ec85b593395a70932610b | wikidoc | ACC/AHA recommendations for surgical intervention in L-transposition of the great arteries | ACC/AHA recommendations for surgical intervention in L-transposition of the great arteries
# Overview
ACC/AHA recommends different surgical options for patients with congenitally corrected/Levo-transposition of the great arteries. In some cases, the technically challenging "double switch operation" has been successful... | ACC/AHA recommendations for surgical intervention in L-transposition of the great arteries
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]; Keri Shafer, M.D. [4]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [5]
# Ov... | https://www.wikidoc.org/index.php/ACC/AHA_recommendations_for_surgical_intervention_in_L-transposition_of_the_great_arteries | |
e0f874b4adbc956fc6809857f23939858cb2831d | wikidoc | Antithrombin Therapy During Percutaneous Coronary Intervention (PCI) (patient information) | Antithrombin Therapy During Percutaneous Coronary Intervention (PCI) (patient information)
IV unfractionated heparin is the most common anticoagulant used in the cath lab.
Mechanism of action
Heparin is a glycosaminoglycan of 12-15 kDa that binds Anti-Thrombin 3 and facilitates its ability to inhibit coagulation factor... | Antithrombin Therapy During Percutaneous Coronary Intervention (PCI) (patient information)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
IV unfractionated heparin is the most common anticoagulant used in the cath lab.
Mechanism of action
Heparin is a glycosaminoglycan of 12-15 kDa that binds Anti-Thrombin 3 and f... | https://www.wikidoc.org/index.php/Antithrombin_Therapy_During_Percutaneous_Coronary_Intervention_(PCI) | |
d78f193957214e751bd96966c12566ca71fd980f | wikidoc | The Living Guidelines: Maintenance of sinus rhythm: Polling Results for CLASS I Guidelines | The Living Guidelines: Maintenance of sinus rhythm: Polling Results for CLASS I Guidelines
# Class I Guidelines
1. Before initiating antiarrhythmic drug therapy, treatment of precipitating or reversible causes of AF is recommended. (Level of Evidence: C)
ACC / AHA 2008 guidelines for diagnosis and management of atria... | The Living Guidelines: Maintenance of sinus rhythm: Polling Results for CLASS I Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for importan... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Maintenance_of_sinus_rhythm:_Polling_Results_for_CLASS_I_Guidelines | |
af6fde544c2644db9c985096060ade79a648ec74 | wikidoc | The Living Guidelines: Preventing Thromboembolism Polling Results for CLASS IIa Guidelines | The Living Guidelines: Preventing Thromboembolism Polling Results for CLASS IIa Guidelines
# Class IIa Guidelines
1. For primary prevention of thromboembolism in patients with non valvular AF who have just 1 of the following validated risk factors, antithrombotic therapy with either aspirin or a vitamin K antagonist i... | The Living Guidelines: Preventing Thromboembolism Polling Results for CLASS IIa Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for importan... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Preventing_Thromboembolism_Polling_Results_for_CLASS_IIa_Guidelines | |
37a8d5b584bf2cbc27da9422b58ce03365f03bbf | wikidoc | The Living Guidelines: Preventing Thromboembolism Polling Results for CLASS IIb Guidelines | The Living Guidelines: Preventing Thromboembolism Polling Results for CLASS IIb Guidelines
# Class IIb Guidelines
1. In patients 75 y of age and older at increased risk of bleeding but without frank contraindications to oral anticoagulant therapy, and in other patients with moderate risk factors for thromboembolism wh... | The Living Guidelines: Preventing Thromboembolism Polling Results for CLASS IIb Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for importan... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Preventing_Thromboembolism_Polling_Results_for_CLASS_IIb_Guidelines | |
e67d28a2f58491da152cc2696f2a54d745c24f62 | wikidoc | University of North Carolina at Chapel Hill Department of Health Policy and Administration | University of North Carolina at Chapel Hill Department of Health Policy and Administration
The Department of Health Policy and Administration (HPAA) is one of eight departments in the School of Public Health at the University of North Carolina at Chapel Hill in the United States. As one of the oldest health management ... | University of North Carolina at Chapel Hill Department of Health Policy and Administration
Template:COI2
The Department of Health Policy and Administration (HPAA) is one of eight departments in the School of Public Health at the University of North Carolina at Chapel Hill in the United States. As one of the oldest hea... | https://www.wikidoc.org/index.php/University_of_North_Carolina_at_Chapel_Hill_Department_of_Health_Policy_and_Administration | |
11949b576328b6448b9654c9954fa458855b3e20 | wikidoc | Guidelines: The ESC/ACC/AHA/WHF Global Task Force Releases New Universal Definition of MI | Guidelines: The ESC/ACC/AHA/WHF Global Task Force Releases New Universal Definition of MI
October 19, 2007 By Scott P. Williams
Sophia Antipolis, France: The much anticipated new universal definition of myocardial infarction (MI) was unveiled today. The definition is scheduled to be published concurrently in the Euro... | Guidelines: The ESC/ACC/AHA/WHF Global Task Force Releases New Universal Definition of MI
October 19, 2007 By Scott P. Williams
[1]
Sophia Antipolis, France: The much anticipated new universal definition of myocardial infarction (MI) was unveiled today. The definition is scheduled to be published concurrently in the... | https://www.wikidoc.org/index.php/Guidelines:_The_ESC/ACC/AHA/WHF_Global_Task_Force_Releases_New_Universal_Definition_of_MI | |
11671e6321cd311d3e41b536773d8752ab75fd87 | wikidoc | ICD-10 Chapter XVII: Congenital malformations, deformations and chromosomal abnormalities | ICD-10 Chapter XVII: Congenital malformations, deformations and chromosomal abnormalities
# Q00-Q89 - Congenital malformations and deformations
## (Q00-Q07) nervous system
- (Q00) Anencephaly and similar malformations
(Q00.0) Anencephaly
Acephaly
(Q00.1) Craniorachischisis
(Q00.2) Iniencephaly
- (Q00.0) Anencephaly
A... | ICD-10 Chapter XVII: Congenital malformations, deformations and chromosomal abnormalities
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
# Q00-Q89 - Congenital malformations and deformations
## (Q00-Q07) nervous system
- (Q00) Anencephaly and similar malformations
(Q00.0) Anencephaly
Acephaly
(Q00.1) Craniorachi... | https://www.wikidoc.org/index.php/ICD-10_Chapter_Q:_Congenital_malformations,_deformations_and_chromosomal_abnormalities | |
9f6cfe7660ec5209f3394791998bebeaa481044c | wikidoc | List of subjects in Gray's Anatomy: X. The Organs of the senses and the Common integument | List of subjects in Gray's Anatomy: X. The Organs of the senses and the Common integument
# the peripheral organs of the special senses
## the organs of taste (Template:GraySubject)
- peripheral gustatory or taste organs
gustatory calyculi (taste-buds)
- gustatory calyculi (taste-buds)
- Structure of taste bud
gustat... | List of subjects in Gray's Anatomy: X. The Organs of the senses and the Common integument
# the peripheral organs of the special senses
## the organs of taste (Template:GraySubject)
- peripheral gustatory or taste organs
gustatory calyculi (taste-buds)
- gustatory calyculi (taste-buds)
- Structure of taste bud
gustat... | https://www.wikidoc.org/index.php/List_of_subjects_in_Gray%27s_Anatomy:223 | |
0cc7e60be5085f5b98b2d0edeb7385c254dfbc13 | wikidoc | ACC AHA recommendations for evaluation of the unoperated patient in atrial septal defect | ACC AHA recommendations for evaluation of the unoperated patient in atrial septal defect
# Overview
ACC/AHA recommends for different diagnostic tools that could be used to evaluate a patient of atrial septal defect
# ACC/AHA recommendations for evaluation of the unoperated patient with atrial septal defect
For ACC/A... | ACC AHA recommendations for evaluation of the unoperated patient in atrial septal defect
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, MBBS [[2]]; Cafer Zorkun, M.D., Ph.D. [3]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [[4]]
# Overview
ACC/AHA recommends for ... | https://www.wikidoc.org/index.php/ACC/AHA_recommendations_for_evaluation_of_the_unoperated_patient_in_atrial_septal_defect | |
3f30cebbfff09c90f083739e4ec215376ba2df76 | wikidoc | Bismuth Subsalicylate, Metronidazole, and Tetracycline Combination (patient information) | Bismuth Subsalicylate, Metronidazole, and Tetracycline Combination (patient information)
# IMPORTANT WARNING
Metronidazole can cause cancer in laboratory animals. However, it is very important to heal ulcers. Talk to your doctor about the risks and benefits of using this combination containing metronidazole in the tre... | Bismuth Subsalicylate, Metronidazole, and Tetracycline Combination (patient information)
Template:Drug header
# IMPORTANT WARNING
Metronidazole can cause cancer in laboratory animals. However, it is very important to heal ulcers. Talk to your doctor about the risks and benefits of using this combination containing me... | https://www.wikidoc.org/index.php/Bismuth_Subsalicylate,_Metronidazole,_and_Tetracycline_Combination | |
91ad2acdf12f25634f3f7a39015219fab9229f94 | wikidoc | Buprenorphine Sublingual and Buprenorphine and Naloxone Sublingual (patient information) | Buprenorphine Sublingual and Buprenorphine and Naloxone Sublingual (patient information)
# Why this medication is prescribed
Buprenorphine (Subutex) and buprenorphine and naloxone (Suboxone) are used to treat opioid dependence (addiction to opioid drugs, including heroin and narcotic painkillers). Buprenorphine is in ... | Buprenorphine Sublingual and Buprenorphine and Naloxone Sublingual (patient information)
Template:Drug header
# Why this medication is prescribed
Buprenorphine (Subutex) and buprenorphine and naloxone (Suboxone) are used to treat opioid dependence (addiction to opioid drugs, including heroin and narcotic painkillers)... | https://www.wikidoc.org/index.php/Buprenorphine_Sublingual_and_Buprenorphine_and_Naloxone_Sublingual | |
e4409bddd34941d081d25435f9e56f6018abc802 | wikidoc | Implantable cardiac defibrillator insertion discharge instructions (patient information) | Implantable cardiac defibrillator insertion discharge instructions (patient information)
# Overview
A surgeon made a small incision (cut) in your chest wall and implanted an implantable cardioverter-defibrillator (ICD) under your skin and muscle. The ICD is the size of a large cookie. Leads, or electrodes, were placed... | Implantable cardiac defibrillator insertion discharge instructions (patient information)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Mohammed A. Sbeih, M.D.[2]
# Overview
A surgeon made a small incision (cut) in your chest wall and implanted an implantable cardioverter-defibrillato... | https://www.wikidoc.org/index.php/Implantable_cardiac_defibrillator_insertion_discharge_instructions_(patient_information) | |
64ad7fcdcf37912e1bcc6b7ae8edaf6c217df676 | wikidoc | Left ventriculography Left Ventricular Ejection Fraction Assessment by Visual Estimation | Left ventriculography Left Ventricular Ejection Fraction Assessment by Visual Estimation
# Overview
Left ventricular ejection fraction (LVEF) can be visually estimated by comparing the contour of the left ventricle (LV) between the end-systolic frame and the end-diastolic frame on left ventriculography.
# Calculation... | Left ventriculography Left Ventricular Ejection Fraction Assessment by Visual Estimation
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
# Overview
Left ventricular ejection fraction (LVEF) can be visually estimated by comparing the contour of the left ventricle (LV) between the end-systolic frame and the end-dias... | https://www.wikidoc.org/index.php/Left_ventriculography_Left_Ventricular_Ejection_Fraction_Assessment_by_Visual_Estimation | |
4b1c69e016666c529643cc7bb31750c09df09bc7 | wikidoc | The Living Guidelines: Preventing Thromboembolism Polling Results for CLASS I Guidelines | The Living Guidelines: Preventing Thromboembolism Polling Results for CLASS I Guidelines
# Class I Guidelines
1. Antithrombotic therapy to prevent thromboembolism is recommended for all patients with AF, except those with lone AF or contraindications. (Level of Evidence: A)
ACC / AHA 2008 guidelines for diagnosis and... | The Living Guidelines: Preventing Thromboembolism Polling Results for CLASS I Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important ... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Preventing_Thromboembolism_Polling_Results_for_CLASS_I_Guidelines | |
7cb7dc488891e9fb05581243b511f0834b0956a9 | wikidoc | HIV opportunistic infection pneumocystis pneumonia: prevention and treatment guidelines | HIV opportunistic infection pneumocystis pneumonia: prevention and treatment guidelines
# Overview
Pneumocystis pneumonia (PCP) is relatively rare in people with normal immune systems but common among people with weakened immune systems, such as premature or severely malnourished children, the elderly, and especially ... | HIV opportunistic infection pneumocystis pneumonia: prevention and treatment guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief:, Ujjwal Rastogi, MBBS [2]
# Overview
Pneumocystis pneumonia (PCP) is relatively rare in people with normal immune systems but common among people wi... | https://www.wikidoc.org/index.php/HIV_opportunistic_infection_pneumocystis_pneumonia:_prevention_and_treatment_guidelines | |
1d32fd7cd53ea4f98266b28d2116936ed8aedbbb | wikidoc | ICD-10 Chapter VII: Diseases of the eye, adnexa; Chapter VIII: ear, and mastoid process | ICD-10 Chapter VII: Diseases of the eye, adnexa; Chapter VIII: ear, and mastoid process
# H00-H59 - Diseases of the eye and adnexa
## (H00-H06) Disorders of eyelid, lacrimal system and orbit
- (H00) Hordeolum and chalazion
(H00.0) Hordeolum and other deep inflammation of eyelid
(H00.1) Chalazion
- (H00.0) Hordeolum a... | ICD-10 Chapter VII: Diseases of the eye, adnexa; Chapter VIII: ear, and mastoid process
# H00-H59 - Diseases of the eye and adnexa
## (H00-H06) Disorders of eyelid, lacrimal system and orbit
- (H00) Hordeolum and chalazion
(H00.0) Hordeolum and other deep inflammation of eyelid
(H00.1) Chalazion
- (H00.0) Hordeolum a... | https://www.wikidoc.org/index.php/ICD-10_Chapter_H:_Diseases_of_the_eye,_adnexa,_ear,_and_mastoid_process | |
73353ab176cdda9a6440f05b038bab4ce3f1510f | wikidoc | ICD-10 Chapter XIX: Injury, poisoning and certain other consequences of external causes | ICD-10 Chapter XIX: Injury, poisoning and certain other consequences of external causes
# S00-T14 - Injury
## (S00-S09) head
- (S00) Superficial injury of head
(S00.0) Superficial injury of scalp
(S00.1) Contusion of eyelid and periocular area
Black eye
(S00.2) Other superficial injuries of eyelid and periocular area... | ICD-10 Chapter XIX: Injury, poisoning and certain other consequences of external causes
# S00-T14 - Injury
## (S00-S09) head
- (S00) Superficial injury of head
(S00.0) Superficial injury of scalp
(S00.1) Contusion of eyelid and periocular area
Black eye
(S00.2) Other superficial injuries of eyelid and periocular area... | https://www.wikidoc.org/index.php/ICD-10_Chapter_S | |
e72fe204f13db94c4fd13f60804452927ed208ef | wikidoc | The Living Guidelines: Pregnant patients: Suggest Revisions to the CLASS IIb Guidelines | The Living Guidelines: Pregnant patients: Suggest Revisions to the CLASS IIb Guidelines
# Class IIb Guidelines
- Administration of heparin may be considered during the first trimester and last month of pregnancy for patients with AF and risk factors for thromboembolism. Unfractionated heparin may be administered eithe... | The Living Guidelines: Pregnant patients: Suggest Revisions to the CLASS IIb Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important i... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Pregnant_patients:_Suggest_Revisions_to_the_CLASS_IIb_Guidelines | |
5cda15e9eee1740758ef110ad64dfc296eed4c6e | wikidoc | The Medicines Company Discontinues Phase 3 CHAMPION Clinical Trial Program of Cangrelor | The Medicines Company Discontinues Phase 3 CHAMPION Clinical Trial Program of Cangrelor
By C. Michael Gibson, M.S., M.D. For Dr. Gibson's disclosures, please click here. Dr. Gibson served as a member of the Executive and Steering Committees for the CHAMPION trial
# CHAMPION Program Discontinued
The phase 3 CHAMPION cl... | The Medicines Company Discontinues Phase 3 CHAMPION Clinical Trial Program of Cangrelor
By C. Michael Gibson, M.S., M.D. For Dr. Gibson's disclosures, please click here. Dr. Gibson served as a member of the Executive and Steering Committees for the CHAMPION trial
# CHAMPION Program Discontinued
The phase 3 CHAMPION c... | https://www.wikidoc.org/index.php/The_Medicines_Company_Discontinues_Phase_3_CHAMPION_Clinical_Trial_Program_of_Cangrelor | |
d246be4c56fc03d76067d2121566a652ee595b33 | wikidoc | Class III recommendations in guidelines for cardiovascular medicine list of guidelines | Class III recommendations in guidelines for cardiovascular medicine list of guidelines
# Overview
A total of 65 guidelines published by American cardiology societies are used to populate all 584 class III recommendations. Only the most updated publication for each guideline and its focused update are chosen to populat... | Class III recommendations in guidelines for cardiovascular medicine list of guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Aparna Vuppala, M.B.B.S. [2]
# Overview
A total of 65 guidelines published by American cardiology societies are used to populat... | https://www.wikidoc.org/index.php/Class_III_recommendations_in_guidelines_for_cardiovascular_medicine_list_of_guidelines | |
c3cda9b5fef862f0606fd684ab3e9d0c0de36a82 | wikidoc | Other specified bipolar disorder due to another medical condition diagnostic criteria | Other specified bipolar disorder due to another medical condition diagnostic criteria
# Diagnostic Criteria
## DSM-V Diagnostic Criteria for Other specified bipolar disorder due to another medical condition:
- This category applies to presentations in which symptoms characteristic of a bipolar and related disorder th... | Other specified bipolar disorder due to another medical condition diagnostic criteria
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nuha Al-Howthi, MD[2]
# Diagnostic Criteria
## DSM-V Diagnostic Criteria for Other specified bipolar disorder due to another medical condition:[1]
- ... | https://www.wikidoc.org/index.php/Other_specified_bipolar_disorder_due_to_another_medical_condition_diagnostic_criteria | |
198b1da992bccfbfc5658bd6152857c28319d04c | wikidoc | The GENESIS Trial Demonstrates Disappointing Results With Pimecrolimus Eluting Stents | The GENESIS Trial Demonstrates Disappointing Results With Pimecrolimus Eluting Stents
March 31, 2008 By Lauren Ciaglo
SCAI-ACCi2 08-Chicago, IL: Results from the GENESIS trial demonstrate that patients treated with CORIO™ (Pimecrolimus-eluting) stents had worse outcomes compared with individuals treated with SYMBIO™ (d... | The GENESIS Trial Demonstrates Disappointing Results With Pimecrolimus Eluting Stents
March 31, 2008 By Lauren Ciaglo
SCAI-ACCi2 08-Chicago, IL: Results from the GENESIS trial demonstrate that patients treated with CORIO™ (Pimecrolimus-eluting) stents had worse outcomes compared with individuals treated with SYMBIO™ (... | https://www.wikidoc.org/index.php/The_GENESIS_Trial_Demonstrates_Disappointing_Results_With_Pimecrolimus_Eluting_Stents | |
44b62bfed53154564bb73996477982b6b973a458 | wikidoc | The Living Guidelines: Pregnant patients: Suggest Revisions to the CLASS I Guidelines | The Living Guidelines: Pregnant patients: Suggest Revisions to the CLASS I Guidelines
# Class I Guidelines
- Digoxin, a beta blocker, or a non dihydropyridine calcium channel antagonist is recommended to control the rate of ventricular response in pregnant patients with AF. (Level of Evidence: C)
- Direct-current car... | The Living Guidelines: Pregnant patients: Suggest Revisions to the CLASS I Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important inf... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Pregnant_patients:_Suggest_Revisions_to_the_CLASS_I_Guidelines | |
daa04b87ab731562e656f509cd045e9376696e80 | wikidoc | Management of Atherosclerotic Risk Factors in Patients With Vertebral Artery Disease | Management of Atherosclerotic Risk Factors in Patients With Vertebral Artery Disease
# Management of Atherosclerotic Risk Factors in Patients With Vertebral Artery Disease
## 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Verte... | Management of Atherosclerotic Risk Factors in Patients With Vertebral Artery Disease
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
# Management of Atherosclerotic Risk Factors in Patients With Vertebral Artery Disease
## 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Manage... | https://www.wikidoc.org/index.php/Management_of_Atherosclerotic_Risk_Factors_in_Patients_With_Vertebral_Artery_Disease | |
d15a5909e7f6ba47e35f1d88f3af358c9e3a5b37 | wikidoc | ACC AHA guidelines for evaluation of unoperated patients with atrial septal defects | ACC AHA guidelines for evaluation of unoperated patients with atrial septal defects
# Overview
Different modalities of treatment could be used to diagnose and determine the amount of shunting across the atrial septal defect. Maximal exercise testing can be used in patients with symptoms that are discrepant with clinic... | ACC AHA guidelines for evaluation of unoperated patients with atrial septal defects
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [4]
# Overview
Different modalities of... | https://www.wikidoc.org/index.php/ACC/AHA_guidelines_for_evaluation_of_unoperated_patients_with_atrial_septal_defects | |
066c14d21f43fc9d616a1740ee9ef10a9a4b6615 | wikidoc | ICD-10 Chapter XVIII: Symptoms, signs and abnormal clinical and laboratory findings | ICD-10 Chapter XVIII: Symptoms, signs and abnormal clinical and laboratory findings
# R00-R69 - Symptoms and signs
## (R00-R09) Circulatory and respiratory systems
- (R00) Abnormalities of heart beat
(R00.0) Tachycardia, unspecified
(R00.1) Bradycardia, unspecified
(R00.2) Palpitations
(R00.8) Other and unspecified a... | ICD-10 Chapter XVIII: Symptoms, signs and abnormal clinical and laboratory findings
# R00-R69 - Symptoms and signs
## (R00-R09) Circulatory and respiratory systems
- (R00) Abnormalities of heart beat
(R00.0) Tachycardia, unspecified
(R00.1) Bradycardia, unspecified
(R00.2) Palpitations
(R00.8) Other and unspecified a... | https://www.wikidoc.org/index.php/ICD-10_Chapter_XVIII:_Symptoms,_signs_and_abnormal_clinical_and_laboratory_findings | |
064b533c1394327680af7ab6c113380aeb076481 | wikidoc | AHA/ASA guideline recommendations for of Early management of acute ischemic stroke | AHA/ASA guideline recommendations for of Early management of acute ischemic stroke
# 2018 AHA/ASA Guidelines for the early Management of Acute Ischemic Stroke
The AHA/ASA published the following guidelines for management of acute ischemic stroke in March, 2018:
## Prehospital Stroke Management
## Designation of Stro... | AHA/ASA guideline recommendations for of Early management of acute ischemic stroke
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2] Syed Hassan A. Kazmi BSc, MD [3]
# 2018 AHA/ASA Guidelines for the early Management of Acute Ischemic Stroke
The AHA/ASA published ... | https://www.wikidoc.org/index.php/AHA/ASA_guideline_recommendations_for_of_Early_management_of_acute_ischemic_stroke | |
d4eaf2f040f5c98b9a4469ffa2c6d9228a8778e4 | wikidoc | HIV opportunistic infection cryptosporidiosis: prevention and treatment guidelines | HIV opportunistic infection cryptosporidiosis: prevention and treatment guidelines
# Overview
Cryptosporidiosis is caused by Cryptosporidium species, a group of protozoan parasites that infect the small bowel mucosa, and in immunosuppressed persons, the large bowel and extraintestinal sites. Those at greatest risk for... | HIV opportunistic infection cryptosporidiosis: prevention and treatment guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief:, Ujjwal Rastogi, MBBS [2]
# Overview
Cryptosporidiosis is caused by Cryptosporidium species, a group of protozoan parasites that infect the small bowel m... | https://www.wikidoc.org/index.php/HIV_opportunistic_infection_cryptosporidiosis:_prevention_and_treatment_guidelines | |
decc4a06b602f9752c234aa6117fd8a51270f937 | wikidoc | Management of chronic limb ischemia in lower extremity peripheral arterial disease | Management of chronic limb ischemia in lower extremity peripheral arterial disease
# 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease
# Recommendations for Management of CLI (critical limb ischemia) in the Patient With PAD
## Recommendation for Revascularization for... | Management of chronic limb ischemia in lower extremity peripheral arterial disease
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Usama Talib, BSc, MD [2]
# 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease[1]
# Recommendations for ... | https://www.wikidoc.org/index.php/Management_of_chronic_limb_ischemia_in_lower_extremity_peripheral_arterial_disease | |
f26da91bedf8427151600a510f737322a10e44bf | wikidoc | Remote ischemic preconditioning may improve clinical outcomes after CABG procedure | Remote ischemic preconditioning may improve clinical outcomes after CABG procedure
August 23, 2007 By Katherine Ogando
London, England: Coronary bypass patients may experience better outcomes following surgery thanks to remote ischemic preconditioning, a technique which induces ischemia and reperfusion in a distant reg... | Remote ischemic preconditioning may improve clinical outcomes after CABG procedure
August 23, 2007 By Katherine Ogando[1]
London, England: Coronary bypass patients may experience better outcomes following surgery thanks to remote ischemic preconditioning, a technique which induces ischemia and reperfusion in a distant... | https://www.wikidoc.org/index.php/Remote_ischemic_preconditioning_may_improve_clinical_outcomes_after_CABG_procedure | |
41353fa7bb4f2176ec890e37354c200b3f83e84b | wikidoc | The Living Guidelines: Pregnant patients: Polling Results for CLASS IIb Guidelines | The Living Guidelines: Pregnant patients: Polling Results for CLASS IIb Guidelines
# Class IIb Guidelines
1. Administration of heparin may be considered during the first trimester and last month of pregnancy for patients with AF and risk factors for thromboembolism. Unfractionated heparin may be administered either by... | The Living Guidelines: Pregnant patients: Polling Results for CLASS IIb Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important inform... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Pregnant_patients:_Polling_Results_for_CLASS_IIb_Guidelines | |
717dab546964a9055f016079b6dbe824c46507d7 | wikidoc | Male pseudohermaphroditism due to 17-beta-hydroxysteroid dehydrogenase deficiency | Male pseudohermaphroditism due to 17-beta-hydroxysteroid dehydrogenase deficiency
Male pseudohermaphroditism due to 17-beta-hydroxysteroid dehydrogenase deficiency is a deficiency of 17-beta-hydroxysteroid dehydrogenase isozyme 3 which leads to male pseudohermaphroditism, a condition characterized by incomplete differe... | Male pseudohermaphroditism due to 17-beta-hydroxysteroid dehydrogenase deficiency
Template:Mergeto
Male pseudohermaphroditism due to 17-beta-hydroxysteroid dehydrogenase deficiency is a deficiency of 17-beta-hydroxysteroid dehydrogenase isozyme 3 which leads to male pseudohermaphroditism, a condition characterized by ... | https://www.wikidoc.org/index.php/17_beta_hydroxysteroide_dehydrogenase_deficiency | |
186b89a0f88e1a641da4b57fd7f163945243cbb5 | wikidoc | Efavirenz, emtricitabine, and tenofovir disoproxil fumarate (patient information) | Efavirenz, emtricitabine, and tenofovir disoproxil fumarate (patient information)
# What is the most important information I should know about ATRIPLA?
Some people who have taken medicine like ATRIPLA (which contains nucleoside analogs) have developed a serious condition called lactic acidosis (build up of an acid in ... | Efavirenz, emtricitabine, and tenofovir disoproxil fumarate (patient information)
Template:Drug header
# What is the most important information I should know about ATRIPLA?
Some people who have taken medicine like ATRIPLA (which contains nucleoside analogs) have developed a serious condition called lactic acidosis (b... | https://www.wikidoc.org/index.php/Efavirenz,_emtricitabine,_and_tenofovir_disoproxil_fumarate_(patient_information) | |
7db6b5f8ec23361e49cf32d8710b8c795fbd4d5d | wikidoc | Electrophysiology study and ablation discharge instructions (patient information) | Electrophysiology study and ablation discharge instructions (patient information)
# Overview
Intracardiac electrophysiology study (EPS) is a test to look at the heart's electrical function. It allows doctors to check for abnormal heartbeats or heart rhythms.
Ablate means "to destroy." Cardiac ablation is a procedure t... | Electrophysiology study and ablation discharge instructions (patient information)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Mohammed A. Sbeih, M.D.[2]
# Overview
Intracardiac electrophysiology study (EPS) is a test to look at the heart's electrical function. It allows doctors to ... | https://www.wikidoc.org/index.php/Electrophysiology_study_and_ablation_discharge_instructions_(patient_information) | |
41e423576d6efba6d6e662948c4dd13b5c8482a7 | wikidoc | ICD-10 Chapter XIII: Diseases of the musculoskeletal system and connective tissue | ICD-10 Chapter XIII: Diseases of the musculoskeletal system and connective tissue
# M00-M99 - Diseases of the musculoskeletal system and connective tissue
## (M00-M25) Arthropathies
### (M00-M03) Infectious arthropathies
- (M00) Pyogenic arthritis
- (M01) Direct infections of joint in infectious and parasitic diseas... | ICD-10 Chapter XIII: Diseases of the musculoskeletal system and connective tissue
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
# M00-M99 - Diseases of the musculoskeletal system and connective tissue
## (M00-M25) Arthropathies
### (M00-M03) Infectious arthropathies
- (M00) Pyogenic arthritis
- (M01) Direct in... | https://www.wikidoc.org/index.php/ICD-10_Chapter_M | |
5012d0935659f709461e933b9e1f4ebd5fd3031f | wikidoc | New formula for predicting long-term survival based on exercise treadmill testing | New formula for predicting long-term survival based on exercise treadmill testing
New formula for predicting long-term survival based on exercise treadmill testing
December 31, 2007 By Benjamin A. Olenchock, M.D. Ph.D.
Cleveland
A new prospective study has evaluated a new mortality prediction rule based on clinical ... | New formula for predicting long-term survival based on exercise treadmill testing
New formula for predicting long-term survival based on exercise treadmill testing
December 31, 2007 By Benjamin A. Olenchock, M.D. Ph.D. [1]
Cleveland
A new prospective study has evaluated a new mortality prediction rule based on clini... | https://www.wikidoc.org/index.php/New_formula_for_predicting_long-term_survival_based_on_exercise_treadmill_testing | |
cfeacbe60699e9bdcb7adcc6206ba98f9f2ba86c | wikidoc | Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery | Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery
Synonyms and keywords: SXscore; SYNTAX; SYNTAX score
# Overview
SYNTAX which is the abbreviation for "Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery" was a prospective clinical trial conducted in 85 sit... | Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: SXscore; SYNTAX; SYNTAX score
# Overview
SYNTAX which is the abbreviation for "Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery" ... | https://www.wikidoc.org/index.php/SYNTAX | |
8fb4aef4e47d2b94af8d3528835489839551ec1c | wikidoc | Guidelines for the management of cerebral vasospasm and DCI associated with aSAH | Guidelines for the management of cerebral vasospasm and DCI associated with aSAH
# 2012 AHA/ASA Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
## Management of Cerebral Vasospasm and DCI After aSAH: Recommendations
†It should be noted that this agent has been shown to improve neuroogical outcomes... | Guidelines for the management of cerebral vasospasm and DCI associated with aSAH
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Sara Mehrsefat, M.D. [2]
# 2012 AHA/ASA Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage[1]
## Management of Cerebral Vasospasm and DCI... | https://www.wikidoc.org/index.php/Guidelines_for_the_management_of_cerebral_vasospasm_and_DCI_associated_with_aSAH | |
c3f7767b1bbff2e091a7486294c0915162e70634 | wikidoc | International Statistical Classification of Diseases and Related Health Problems | International Statistical Classification of Diseases and Related Health Problems
# Background
For implantable defibrillators see AICD
The International Statistical Classification of Diseases and Related Health Problems (most commonly known by the abbreviation ICD) provides codes to classify diseases and a wide variety... | International Statistical Classification of Diseases and Related Health Problems
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
# Background
For implantable defibrillators see AICD
The International Statistical Classification of Diseases and Related Health Problems (most commonly known by the abbreviation ICD) pr... | https://www.wikidoc.org/index.php/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems | |
094c83cc3f2b6849dd5596e64ed1ad293b0148d7 | wikidoc | The Living Guidelines: Pregnant patients: Polling Results for CLASS I Guidelines | The Living Guidelines: Pregnant patients: Polling Results for CLASS I Guidelines
# Class I Guidelines
1. Digoxin, a beta blocker, or a non dihydropyridine calcium channel antagonist is recommended to control the rate of ventricular response in pregnant patients with AF. (Level of Evidence: C)
ACC / AHA 2008 guideline... | The Living Guidelines: Pregnant patients: Polling Results for CLASS I Guidelines
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important informat... | https://www.wikidoc.org/index.php/The_Living_Guidelines:_Pregnant_patients:_Polling_Results_for_CLASS_I_Guidelines | |
8dfe9f652129d610d0abfa434dc7c2e35ec9f220 | wikidoc | Unclassified Class III recommendations in guidelines for cardiovascular medicine | Unclassified Class III recommendations in guidelines for cardiovascular medicine
# Overview
Unclassified LOE is noted when the guideline does not report the level of evidence. The total number of class III recommendations with unclassified LOE in guidelines published by American cardiology societies is 21.
# Class II... | Unclassified Class III recommendations in guidelines for cardiovascular medicine
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Aparna Vuppala, M.B.B.S. [2]
# Overview
Unclassified LOE is noted when the guideline does not report the level of evidence. The total... | https://www.wikidoc.org/index.php/Unclassified_Class_III_recommendations_in_guidelines_for_cardiovascular_medicine | |
946c0ec2cbcafc4f7715c5667f6c97298ca109e7 | wikidoc | Advanced Chronic Heart Failure Clinical Assessment Of Immune Modulation Therapy | Advanced Chronic Heart Failure Clinical Assessment Of Immune Modulation Therapy
# Complete Title of Study
A Multi-Center, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess the Effects of the Celacade™ System on Mortality and Morbidity in Patients With Chronic Heart Failure
# Study Acronym (... | Advanced Chronic Heart Failure Clinical Assessment Of Immune Modulation Therapy
How to edit trial information: Log in, click on the word [edit] to the right of the section you would like to edit, type in the appropriate information, click save page at the bottom when you are done. The template is the minimum elements... | https://www.wikidoc.org/index.php/ACCLAIM | |
1721886fda2158d4bc2d9e1309b67ce7281e550d | wikidoc | Azithromycin And Coronary Events Study In Patients With Stable Coronary Disease | Azithromycin And Coronary Events Study In Patients With Stable Coronary Disease
# Complete Title of Study
None reported
# Study Acronym (The trial's abbreviation if there is one)
None reported
# Principal Investigator, Co-investigators, and Collaborating Institutions
None reported
# Overview of Trial
None reported
... | Azithromycin And Coronary Events Study In Patients With Stable Coronary Disease
How to edit trial information: Log in, click on the word [edit] to the right of the section you would like to edit, type in the appropriate information, click save page at the bottom when you are done. The template is the minimum elements... | https://www.wikidoc.org/index.php/ACES | |
76dadb9f7173ef8a7e4030267f41e9a5dd5b20cb | wikidoc | ST Elevation Myocardial Infarction in a Rare Variant of Single Coronary Anomaly | ST Elevation Myocardial Infarction in a Rare Variant of Single Coronary Anomaly
# Authors
Bhalaghuru Chokkalingam Mani, MD1; Alec Vishnevsky, MD2; Ethan J. Halperin, MD2; David L. Fischman, MD2
1From Novant Heart and Vascular Institute, Matthews, NC; 2From the Department of Medicine, Division of Cardiology, Sidney Kim... | ST Elevation Myocardial Infarction in a Rare Variant of Single Coronary Anomaly
Click here to go back to the Tweetbook
Click here to read more about anomalous origins of coronary arteries on WikiDoc
# Authors
Bhalaghuru Chokkalingam Mani, MD1; Alec Vishnevsky, MD2; Ethan J. Halperin, MD2; David L. Fischman, MD2
1From... | https://www.wikidoc.org/index.php/ST_Elevation_Myocardial_Infarction_in_a_Rare_Variant_of_Single_Coronary_Anomaly | |
1b2195d9e0baab8661e1344fbdd32a32c2b01c27 | wikidoc | AHA, ASA guidelines for the management of spontaneous intracerebral hemorrhage | AHA, ASA guidelines for the management of spontaneous intracerebral hemorrhage
# 2015 AHA/ASA Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
## Emergency Diagnosis and Assessment: Recommendations
## Hemostasis and Coagulopathy, Antiplatelet Agents, and DVT Prophylaxis: Recommendations
### Pat... | AHA, ASA guidelines for the management of spontaneous intracerebral hemorrhage
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]
# 2015 AHA/ASA Guidelines for the Management of Spontaneous Intracerebral Hemorrhage[1]
## Emergency Diagnosis and Assessment: Reco... | https://www.wikidoc.org/index.php/AHA,_ASA_guidelines_for_the_management_of_spontaneous_intracerebral_hemorrhage | |
084665c89ef50283b30f948cb9f128a4d3c3e246 | wikidoc | Association of Medical Superintendents of American Institutions for the Insane | Association of Medical Superintendents of American Institutions for the Insane
The Association of Medical Superintendents of American Institutions for the Insane, also known as The Superintendents' Association, was organized in Philadelphia in October, 1844 at a meeting of 13 superintendents, making it the first profes... | Association of Medical Superintendents of American Institutions for the Insane
The Association of Medical Superintendents of American Institutions for the Insane, also known as The Superintendents' Association, was organized in Philadelphia in October, 1844 at a meeting of 13 superintendents, making it the first profe... | https://www.wikidoc.org/index.php/Association_of_Medical_Superintendents_of_American_Institutions_for_the_Insane | |
1c0f834c9a92c684f6d4c65e70170946278dfe0c | wikidoc | Bannayan-Riley-Ruvalcaba syndrome natural history, complications and prognosis | Bannayan-Riley-Ruvalcaba syndrome natural history, complications and prognosis
# Overview
The symptoms of BRRS usually develop in the first decade of life.The prognosis is unknown for Bannayan-Riley-Ruvalcaba syndrome (BRRS).
# Natural History, Complications, and Prognosis
Natural History
- The symptoms of BRRS usual... | Bannayan-Riley-Ruvalcaba syndrome natural history, complications and prognosis
Template:Bannayan-Riley-Ruvalcaba syndrome
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
# Overview
The symptoms of BRRS usually develop in the first decade of life.The p... | https://www.wikidoc.org/index.php/Bannayan-Riley-Ruvalcaba_syndrome_natural_history,_complications_and_prognosis | |
a6fdb06f979b60d37c24cb37751a4b812f5a4b1a | wikidoc | Carvedilol Post Infarct Survival Control in Left Ventricular Dysfunction Study | Carvedilol Post Infarct Survival Control in Left Ventricular Dysfunction Study
CAPRICORN = Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction Study
# Overview
A multicenter, multinational, double-blind, randomized, placebo-controlled trial that enrolled 1,959 patients who had an acute MI and a le... | Carvedilol Post Infarct Survival Control in Left Ventricular Dysfunction Study
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
CAPRICORN = Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction Study
# Overview
A multicenter, multinational... | https://www.wikidoc.org/index.php/CAPRICORN | |
89d0e7051c8c3b6034ade8e6210382d36c11ff8a | wikidoc | Risk stratification in the patient with unstable angina or non ST elevation MI | Risk stratification in the patient with unstable angina or non ST elevation MI
# Definition
- Unstable angina: acute ischemic symptoms, with or without EKG changes (ST depression/transient ST elevation/new T wave inversion), and absence of troponin or CK-MB elevation.
- Non ST elevation MI: acute ischemic symptoms, wi... | Risk stratification in the patient with unstable angina or non ST elevation MI
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
# Definition
- Unstable angina: acute ischemic symptoms, with or without EKG changes (ST depression/transient ST elevation/new T wave inversion), and absence of troponin or CK-MB elevation... | https://www.wikidoc.org/index.php/Risk_Stratification_in_the_Patient_with_Unstable_Angina_or_Non_ST_Elevation_MI | |
6a535046d9f3fae82a179ebb0c40b6f13cd2e23b | wikidoc | Texas Tech University Health Sciences Center School of Pharmacy Abilene Campus | Texas Tech University Health Sciences Center School of Pharmacy Abilene Campus
Texas Tech University Health Sciences Center School of Pharmacy Abilene Campus opened on August 12, 2007. Classes are held in a Spanish-themed 36,000 square-foot building, constructed at a cost of US$15.5 million. The initial enrollment of 4... | Texas Tech University Health Sciences Center School of Pharmacy Abilene Campus
Texas Tech University Health Sciences Center School of Pharmacy Abilene Campus opened on August 12, 2007. Classes are held in a Spanish-themed 36,000 square-foot building, constructed at a cost of US$15.5 million. The initial enrollment of ... | https://www.wikidoc.org/index.php/Texas_Tech_University_Health_Sciences_Center_School_of_Pharmacy_Abilene_Campus | |
a762b0d189080aa06a034b3f7ca9f11aa95ac9ee | wikidoc | Ticarcillin Disodium and Clavulanate Potassium Injection (patient information) | Ticarcillin Disodium and Clavulanate Potassium Injection (patient information)
# About your treatment
Your doctor has ordered ticarcillin and clavulanate, an antibiotic, to help treat your infection. It will be added to an intravenous fluid that will drip through a needle or catheter placed in your vein for about 30 m... | Ticarcillin Disodium and Clavulanate Potassium Injection (patient information)
Template:Drug header
# About your treatment
Your doctor has ordered ticarcillin and clavulanate, an antibiotic, to help treat your infection. It will be added to an intravenous fluid that will drip through a needle or catheter placed in yo... | https://www.wikidoc.org/index.php/Ticarcillin_Disodium_and_Clavulanate_Potassium_Injection_(patient_information) | |
32ab956cce51a61af8bb912ea92b1bf5f28a3ecf | wikidoc | APA Task Force on Deceptive and Indirect Techniques of Persuasion and Control | APA Task Force on Deceptive and Indirect Techniques of Persuasion and Control
The APA Task Force on Deceptive and Indirect Techniques of Persuasion and Control (DIMPAC) was formed at the request of the American Psychological Association (APA) in 1983. The APA asked Margaret Singer, who was one of the leading proponents... | APA Task Force on Deceptive and Indirect Techniques of Persuasion and Control
The APA Task Force on Deceptive and Indirect Techniques of Persuasion and Control (DIMPAC) was formed at the request of the American Psychological Association (APA) in 1983. The APA asked Margaret Singer, who was one of the leading proponent... | https://www.wikidoc.org/index.php/APA_Task_Force_on_Deceptive_and_Indirect_Techniques_of_Persuasion_and_Control | |
3ea7605944d3636767365573aabf582512604448 | wikidoc | Hepatology, Gallbladder, and Biliary Tract Diseases Project Mission Statement | Hepatology, Gallbladder, and Biliary Tract Diseases Project Mission Statement
# WikiDoc Oncology Project — Mission Statement
- Thank you for your interest in the WikiDoc Hepatology, Gallbladder, and Biliary Tract Diseases Project.
- The project aims to integrate current body of medical literature into treatment strate... | Hepatology, Gallbladder, and Biliary Tract Diseases Project Mission Statement
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Serge Korjian M.D.
# WikiDoc Oncology Project — Mission Statement
- Thank you for your interest in the WikiDoc Hepatology, Gallbladder, a... | https://www.wikidoc.org/index.php/Hepatology,_Gallbladder,_and_Biliary_Tract_Diseases_Project_Mission_Statement | |
4d3b7ac838bb4141f3e65316cc2727519ced5a46 | wikidoc | Norelgestromin and ethinyl estradiol transdermal system (patient information) | Norelgestromin and ethinyl estradiol transdermal system (patient information)
# IMPORTANT WARNING:
Cigarette smoking increases the risk of serious side effects from the contraceptive patch, including heart attacks, blood clots, and strokes. This risk is higher for women over 35 years old and heavy smokers (15 or more ... | Norelgestromin and ethinyl estradiol transdermal system (patient information)
Template:Drug header
# IMPORTANT WARNING:
Cigarette smoking increases the risk of serious side effects from the contraceptive patch, including heart attacks, blood clots, and strokes. This risk is higher for women over 35 years old and heav... | https://www.wikidoc.org/index.php/Norelgestromin_and_ethinyl_estradiol_transdermal_system_(patient_information) | |
add4ad9b80f196349ea70a1b360fc5643a88e231 | wikidoc | AHA/ASA guideline recommendations for prevention of stroke in women | AHA/ASA guideline recommendations for prevention of stroke in women overview
# Overview
The incidence of stroke, especially in women, is fast-rising. Stroke is the third leading cause of death in women and fifth in men. Many studies have documented the fact that women are more adversely affected by stroke and its co... | AHA/ASA guideline recommendations for prevention of stroke in women overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]
# Overview
The incidence of stroke, especially in women, is fast-rising. Stroke is the third leading cause of death in women ... | https://www.wikidoc.org/index.php/AHA/ASA_guideline_recommendations_for_prevention_of_stroke_in_women_overview | |
5cd108269678f3f0a6a3c1cc72466840b4c0e972 | wikidoc | Clinical Outcomes Utilizing Revascularization And Aggressive Drug Evaluation | Clinical Outcomes Utilizing Revascularization And Aggressive Drug Evaluation
Synonyms and keywords: COURAGE, COURAGE trial
# Overview
The COURAGE (Clinical Outcomes Utilizing Revascularization and AGgressive Drug Evaluation) trial , was a large-scale, randomized, multicenter, multinational trial conducted between 1999... | Clinical Outcomes Utilizing Revascularization And Aggressive Drug Evaluation
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In Chief: Lakshmi Gopalakrishnan, M.B.B.S.
Synonyms and keywords: COURAGE, COURAGE trial
# Overview
The COURAGE (Clinical Outcomes Utilizing Revascularization and AGgressiv... | https://www.wikidoc.org/index.php/COURAGE | |
44061134d6233d0fa54f99f172aeff7a92899a34 | wikidoc | Cardiac risk assessment prior to non-cardiac surgery resident survival guide | Cardiac risk assessment prior to non-cardiac surgery resident survival guide
# Overview
Cardiac complications are potential risks of non-cardiac surgeries and interventions. Non-cardiac surgery is associated with a 7% to 11% overall complication rate, approximately half of which are cardiac in nature. The risk of per... | Cardiac risk assessment prior to non-cardiac surgery resident survival guide
# Overview
Cardiac complications are potential risks of non-cardiac surgeries and interventions. Non-cardiac surgery is associated with a 7% to 11% overall complication rate, approximately half of which are cardiac in nature. The risk of per... | https://www.wikidoc.org/index.php/Cardiac_risk_assessment_for_noncardiac_surgery_resident_survival_guide | |
d566a5409074f09b74f5c457c83dfbb174b8f429 | wikidoc | Clinical event adjudication: Peripheral arterial revascularization procedure | Clinical event adjudication: Peripheral arterial revascularization procedure
For the list of clinical event adjudication definitions, click here
# Peripheral arterial revascularization procedure
This chapter presents peripheral arterial revascularization procedure definitions used in the Clinical Event Committee adjud... | Clinical event adjudication: Peripheral arterial revascularization procedure
For the list of clinical event adjudication definitions, click here
Editors-in-Chief: C. Michael Gibson, M.S., M.D. [1]
# Peripheral arterial revascularization procedure
This chapter presents peripheral arterial revascularization procedure d... | https://www.wikidoc.org/index.php/Clinical_event_adjudication:_Peripheral_arterial_revascularization_procedure | |
977a51e2cce16abe64f6448e0b6b510335e9db42 | wikidoc | Downstream transcription factor II B recognition element gene transcriptions | Downstream transcription factor II B recognition element gene transcriptions
The downstream B recognition element designated as the BREd, or dBRE, is an additional core promoter element that occurs downstream of the TATA box and is recognized by general transcription factor II B.
# Consensus sequences
A consensus sequ... | Downstream transcription factor II B recognition element gene transcriptions
Editor-In-Chief: Henry A. Hoff
Template:TOCright
The downstream B recognition element designated as the BREd,[1] or dBRE, is an additional core promoter element that occurs downstream of the TATA box and is recognized by general transcription... | https://www.wikidoc.org/index.php/Downstream_transcription_factor_II_B_recognition_element_gene_transcriptions | |
0d11e2ec3b589ac495390362d4b793aad2b0d285 | wikidoc | Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium | Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium
# Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any f... | Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]; Ammu Susheela, M.D. [3]
# Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is i... | https://www.wikidoc.org/index.php/Drospirenone/ethinyl_estradiol/levomefolate_calcium_and_levomefolate_calcium | |
22db74cb176a85b6cf72fc0099026516a23ad921 | wikidoc | Emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide fumarate | Emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide fumarate
# Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any f... | Emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide fumarate
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Allison Tu [2]
# Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a... | https://www.wikidoc.org/index.php/Emtricitabine,_rilpivirine_hydrochloride,_and_tenofovir_alafenamide_fumarate | |
674f4a4583eb27ffc1402057d7a2e3ec7a72cf92 | wikidoc | Hepatology, Gallbladder, and Biliary Tract Diseases Project Chapter Priority | Hepatology, Gallbladder, and Biliary Tract Diseases Project Chapter Priority
# Overview
Start adding content to chapters of the highest priority first (priority 1). Once all chapters of a priority level are successfully completed, move to the chapters of the subsequent priority level.
# Distribution of Chapters by Pr... | Hepatology, Gallbladder, and Biliary Tract Diseases Project Chapter Priority
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Yazan Daaboul, M.D.; Serge Korjian M.D.
# Overview
Start adding content to chapters of the highest priority first (priority 1). Once all chapters of a priority... | https://www.wikidoc.org/index.php/Hepatology,_Gallbladder,_and_Biliary_Tract_Diseases_Project_Chapter_Priority | |
c5c59fc44bd6b8db6b3ae273c039d997149e1fce | wikidoc | Antihypertensive and lipid-lowering treatment to prevent heart attack trial | Antihypertensive and lipid-lowering treatment to prevent heart attack trial
# Overview
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) trial compared major outcomes in high risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel block... | Antihypertensive and lipid-lowering treatment to prevent heart attack trial
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Click here to download slides for ALLHAT trial.
# Overview
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) trial compared major outcomes in high risk ... | https://www.wikidoc.org/index.php/Antihypertensive_And_Lipid-Lowering_Treatment_To_Prevent_Heart_Attack_Trial | |
0dcaf260607a4d90219938ffc811bfcaf58871ef | wikidoc | Cardiac allograft vasculopathy natural history, complications and prognosis | Cardiac allograft vasculopathy natural history, complications and prognosis
# Overview
CAV is responsible for approximately 40% of deaths in heart transplant recipients. Survival in these patients has improved significantly over the decades, owing primarily to improved diagnostic techniques, and optimal immunosuppress... | Cardiac allograft vasculopathy natural history, complications and prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]; Raviteja Guddeti, M.B.B.S. [3]
# Overview
CAV is responsible for approximately 40% of deaths in heart transplant recipients. Surviv... | https://www.wikidoc.org/index.php/Cardiac_allograft_vasculopathy_natural_history,_complications_and_prognosis | |
d1551f1a4fc52ac8e65e40a39262cdca58ca4b9e | wikidoc | Emtricitabine, Rilpivirine Hydrochloride, And Tenofovir Disoproxil Fumarate | Emtricitabine, Rilpivirine Hydrochloride, And Tenofovir Disoproxil Fumarate
# Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any fo... | Emtricitabine, Rilpivirine Hydrochloride, And Tenofovir Disoproxil Fumarate
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Deepika Beereddy, MBBS [2]
# Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replac... | https://www.wikidoc.org/index.php/Complera | |
10e8037adefb43a4eb0d0bbc07609da0661f92fd | wikidoc | HIPAA deidentification and reidentification of patients and patient privacy | HIPAA deidentification and reidentification of patients and patient privacy
# De-identification and its Rationale
The increasing adoption of health information technologies in the United States accelerates their potential to facilitate beneficial studies that combine large, complex data sets from multiple sources. Th... | HIPAA deidentification and reidentification of patients and patient privacy
# De-identification and its Rationale
The increasing adoption of health information technologies in the United States accelerates their potential to facilitate beneficial studies that combine large, complex data sets from multiple sources. Th... | https://www.wikidoc.org/index.php/HIPAA_deidentification_and_reidentification_of_patients_and_patient_privacy | |
f413c47e606e4649f6308dfc698fdb45a0399062 | wikidoc | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate
# Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any for... | Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Disoproxil Fumarate
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alonso Alvarado, M.D. [2]
# Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacem... | https://www.wikidoc.org/index.php/Elvitegravir,_Cobicistat,_Emtricitabine,_And_Tenofovir_Disoproxil_Fumarate | |
ed0916af5d7ab5548bc19d4e418b1959f9d6c659 | wikidoc | Estrogen and Progestin (Hormone Replacement Therapy) (patient information) | Estrogen and Progestin (Hormone Replacement Therapy) (patient information)
# IMPORTANT WARNING
Hormone replacement therapy may increase the risk of heart attack, stroke, breast cancer, and blood clots in the lungs and legs. Tell your doctor if you smoke and if you have or have ever had breast lumps or cancer; a heart ... | Estrogen and Progestin (Hormone Replacement Therapy) (patient information)
Template:Drug header
# IMPORTANT WARNING
Hormone replacement therapy may increase the risk of heart attack, stroke, breast cancer, and blood clots in the lungs and legs. Tell your doctor if you smoke and if you have or have ever had breast lum... | https://www.wikidoc.org/index.php/Estrogen_and_Progestin | |
366246fd48d4be5023d6b10ac9ab901c84d88b53 | wikidoc | Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes | Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes
# Overview
Mitochondrial myopathy, encephalopathy, lactic acidosis, stroke-like episodes, abbreviated to MELAS is one of the family of mitochondrial cytopathies, which also include MERRF, and Leber's Hereditary Optic Atrophy. A feature of thes... | Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
# Overview
Mitochondrial myopathy, encephalopathy, lactic acidosis, stroke-like episodes, abbreviated to MELAS is one of the family of mitochondrial cytopathies,... | https://www.wikidoc.org/index.php/MELAS | |
1afffedb50059cee589bc0d187d690d22ae1977a | wikidoc | Recommendation for Duration of DAPT in Patients With ACS Treated With CABG | Recommendation for Duration of DAPT in Patients With ACS Treated With CABG
# 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
# Duration of DAPT in Patients With ACS Treated With CABG:Recommendation
- ↑ Levine GN, Bates ER, Bittl JA, Brindis RG, F... | Recommendation for Duration of DAPT in Patients With ACS Treated With CABG
# 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease[1]
# Duration of DAPT in Patients With ACS Treated With CABG:Recommendation
- ↑ Levine GN, Bates ER, Bittl JA, Brindis RG... | https://www.wikidoc.org/index.php/Recommendation_for_Duration_of_DAPT_in_Patients_With_ACS_Treated_With_CABG | |
95e8d2a1ba339f5aac9994621f0ceb3eafba50b2 | wikidoc | Sandbox:Zika virus infection natural history, complications, and prognosis | Sandbox:Zika virus infection natural history, complications, and prognosis
# Overview
# Natural History
- The symptoms of Zika virus infection usually develop between 3 and 12 days after contraction.
- Zika virus infection symptoms will usually begin with a mild headache. Within 24 hours, they will progress to includ... | Sandbox:Zika virus infection natural history, complications, and prognosis
To go back to the main page, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S.
# Overview
# Natural History
- The symptoms of Zika virus infection usually develop between... | https://www.wikidoc.org/index.php/Sandbox:Zika_virus_infection_natural_history,_complications,_and_prognosis | |
af1155c96ee32f8ce6024ea2ebe03e23c28d462d | wikidoc | Elvitegravir cobicistat emtricitabine tenofovir dosage and administration | Elvitegravir cobicistat emtricitabine tenofovir dosage and administration
# Dosage and Administration
## Dosage Information
The recommended dosage of STRIBILD is one tablet taken orally once daily with food .
## Dosage Adjustment in Patients with Renal Impairment
Initiation of STRIBILD in patients with estimated cre... | Elvitegravir cobicistat emtricitabine tenofovir dosage and administration
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
# Dosage and Administration
## Dosage Information
The recommended dosage of STRIBILD is one tablet taken orally once daily with food ... | https://www.wikidoc.org/index.php/Elvitegravir_cobicistat_emtricitabine_tenofovir_dosage_and_administration | |
cfe4c43b163dbb696913d92bc6260eef201032ec | wikidoc | Piperacillin sodium and tazobactam sodium injection (patient information) | Piperacillin sodium and tazobactam sodium injection (patient information)
# About your treatment
Your doctor has prescribed piperacillin and tazobactam, an antibiotic, to help treat your infection. The drug will be added to an intravenous fluid that will drip through a needle or catheter placed in your vein for 30 min... | Piperacillin sodium and tazobactam sodium injection (patient information)
Template:Drug header
# About your treatment
Your doctor has prescribed piperacillin and tazobactam, an antibiotic, to help treat your infection. The drug will be added to an intravenous fluid that will drip through a needle or catheter placed i... | https://www.wikidoc.org/index.php/Piperacillin_sodium_and_tazobactam_sodium | |
8e98ddc0d0e0348bd1d7cb7e27f4e47166d5b12c | wikidoc | Safety, Tolerability and Pharmacokinetics of CSL112 in Healthy Volunteers | Safety, Tolerability and Pharmacokinetics of CSL112 in Healthy Volunteers
# Official Title
An Adaptive, Phase I, Single-Centre, Randomised, Double-blind, Placebo-controlled Single Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics, of Intravenous CSL112 in Healthy Volunteers
# Objective... | Safety, Tolerability and Pharmacokinetics of CSL112 in Healthy Volunteers
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
# Official Title
An Adaptive, Phase I, Single-Centre, Randomised, Double-blind, Placebo-controlled Single Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics, of I... | https://www.wikidoc.org/index.php/Safety,_Tolerability_and_Pharmacokinetics_of_CSL112_in_Healthy_Volunteers | |
95e6b2cbac3331571d8d1d007c2e8e7654e6a3f1 | wikidoc | Sudden infant death syndrome natural history, complications and prognosis | Sudden infant death syndrome natural history, complications and prognosis
# Overview
Common complications of SIDS include sudden unexplained death. Depending on the risk factors for recurrence, the prognosis may vary for SIDS. SIDS is typically unexplained death during without any prior symptoms.
# Natural History, C... | Sudden infant death syndrome natural history, complications and prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S [2]
# Overview
Common complications of SIDS include sudden unexplained death. Depending on the risk factors for recurrence, the progn... | https://www.wikidoc.org/index.php/Sudden_infant_death_syndrome_natural_history,_complications_and_prognosis | |
44271561588de94ac325949bcedc047a623053a9 | wikidoc | The EKG in the patient treated with encainide, flecainide and propafenone | The EKG in the patient treated with encainide, flecainide and propafenone
# Electrocardiographic Findings
- Prolong the PR and the QRS
- Propafenone may also slow the sinus rate due to its β-blocking effects
# Additional resources
- ECGpedia: Course for interpretation of ECG
- The whole ECG - A basic ECG primer
- 12-... | The EKG in the patient treated with encainide, flecainide and propafenone
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
# Electrocardiographic Findings
- Prolong the PR and the QRS
- Propafenone may also slow the sinus rate due to its β-blocking effects
# Additional resources
- ECGpedia: Course for interpretati... | https://www.wikidoc.org/index.php/The_EKG_in_the_Patient_Treated_with_Encainide,_Flecainide_and_Propafenone | |
9a58157d64b8cd76ea3097af838e4156c85f4a25 | wikidoc | Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A | Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A
Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A is a type II membrane protein and an enzyme – particularly a glycosyltransferase – that, in addition to the related isoenzyme B (MGAT4B), takes part in the transfer of N-acet... | Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A
Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A is a type II membrane protein and an enzyme – particularly a glycosyltransferase – that, in addition to the related isoenzyme B (MGAT4B),[1] takes part in the transfer of N-... | https://www.wikidoc.org/index.php/Alpha-1,3-mannosyl-glycoprotein_4-beta-N-acetylglucosaminyltransferase_A | |
848b640cfb412cdd3dfbb8995835b63b7d78dfc7 | wikidoc | Belladonna Alkaloid Combinations and Phenobarbital (patient information) | Belladonna Alkaloid Combinations and Phenobarbital (patient information)
# Why this medication was prescribed
Belladonna alkaloid combinations and phenobarbital are used to relieve cramping pains in conditions such as irritable bowel syndrome and spastic colon. They also are used with other medicine to treat ulcers. T... | Belladonna Alkaloid Combinations and Phenobarbital (patient information)
Template:Drug header
# Why this medication was prescribed
Belladonna alkaloid combinations and phenobarbital are used to relieve cramping pains in conditions such as irritable bowel syndrome and spastic colon. They also are used with other medic... | https://www.wikidoc.org/index.php/Belladonna_Alkaloid_Combinations_and_Phenobarbital | |
c1912229bd17b300f3c4f465d128fb95e419485b | wikidoc | Buprenorphine Hydrochloride/Naloxone Hydrochloride (patient information) | Buprenorphine Hydrochloride/Naloxone Hydrochloride (patient information)
# Why is this medication prescribed?
Buprenorphine (Subutex) and buprenorphine and naloxone (Suboxone) are used to treat opioid dependence (addiction to opioid drugs, including heroin and narcotic painkillers). Buprenorphine is in a class of medi... | Buprenorphine Hydrochloride/Naloxone Hydrochloride (patient information)
Template:Drug header
# Why is this medication prescribed?
Buprenorphine (Subutex) and buprenorphine and naloxone (Suboxone) are used to treat opioid dependence (addiction to opioid drugs, including heroin and narcotic painkillers). Buprenorphine... | https://www.wikidoc.org/index.php/Buprenorphine_Hydrochloride/Naloxone_Hydrochloride_(patient_information) | |
ad6638f0837d03fc87d30bea0bb7b060c49bae0c | wikidoc | Comparison of allopathic and osteopathic physicians in the United States | Comparison of allopathic and osteopathic physicians in the United States
This article discusses similarities and differences between allopathic and osteopathic physicians in the United States. For the sake of comparison, holders of an M.D. are sometimes referred to as allopathic physicians, while those with a D.O. are... | Comparison of allopathic and osteopathic physicians in the United States
Template:Physician education and training in the United States
This article discusses similarities and differences between allopathic and osteopathic physicians in the United States. For the sake of comparison, holders of an M.D. are sometimes r... | https://www.wikidoc.org/index.php/Comparison_of_M.D._and_D.O. |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.